Transfusion in Cardiac Valve Surgery

NANot yet recruitingINTERVENTIONAL
Enrollment

1,600

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

December 30, 2027

Study Completion Date

December 30, 2027

Conditions
Cardiac Surgery With Cardiopulmonary BypassValve Heart Disease
Interventions
OTHER

Restrictive Transfusion Strategy

Blood transfusion at HCT less than 21% or Hb less than 6.0g/dL during CPB, at HCT less than 21% or Hb less than 7.0g/dL in ICU or general ward after surgery

OTHER

Liberal Transfusion Strategy

Blood transfusion at HCT less than 24% or Hb less than 8.0g/dL during CPB, at HCT less than 30% or Hb less than 10.0g/dL in ICU or general ward after surgery

Trial Locations (1)

510145

Guangdong Provincial People's Hospital, Guangzhou

All Listed Sponsors
lead

Guangdong Provincial People's Hospital

OTHER

NCT06332547 - Transfusion in Cardiac Valve Surgery | Biotech Hunter | Biotech Hunter